Live Breaking News & Updates on Sagar Nigwekar

Stay updated with breaking news from Sagar nigwekar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Inozyme Pharma Reports Full Year 2023 Financial Results and Provides Business Highlights

– Topline data from ongoing Phase 1/2 trials of INZ-701 in adults with ABCC6 Deficiency and ENPP1 Deficiency expected in early April –– Phase 1 tr. ....

United States , Douglasa Treco , Stefan Riley , Christine Obrien , Inozyme Pharma , Matt Pera , Sagar Nigwekar , European Calcified Tissue Society Congress , Corporate Communications , Exchange Commission , American Society Of Nephrology , Company Or Inozyme , Kidney Research Center , Inozyme Pharma Inc , Development Rd Expenses , Patient Registry , Christineo Brien , Hemodialysis Now Underway , American Society , Kidney Week , Massachusetts General , Early April , Year Ended December , Financial Guidance , Private Securities Litigation Reform Act , Annual Report ,

Inozyme Pharma Announces Presentation at the American Society of Nephrology (ASN) Kidney Week 2023 - Inozyme Pharma (NASDAQ:INZY)

BOSTON, Oct. 26, 2023 (GLOBE NEWSWIRE) Inozyme Pharma, Inc. (NASDAQ:INZY) ("Inozyme" or the "Company"), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of ....

United States , Inozyme Pharma , Sagar Nigwekar , Stefan Riley , Matt Pera , Research Advances In Bone , Drug Administration , Inozyme Pharma Inc , European Calcified Tissue Society Congress , Corporate Communications , American Society Of Nephrology , Kidney Research Center , Exchange Commission , Mmsc Co , American Society , Kidney Week , Plasma Inorganic Pyrophosphate , Oral Abstract Session , Research Advances , Api Chewcharat , Clinical Fellow , Massachusetts General Hospital , Private Securities Litigation Reform Act , Annual Report ,